NDC 79884-001-01 - RX300 Topical Pain Cream Pain Cream
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 79884-001
- Requested NDC
- 79884-001-01
- Package NDCs from labels
- 79884-001-01, 79884-001-02
- Manufacturer
- BENERX LLC | Dhaliwal Pharmaceuticals Laboratories LLC
- Effective date
- 2022-12-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MENTHOL, LIDOCAINE - BENERX LLC | Dhaliwal Pharmaceuticals Laboratories LLC | BENERX LLC | Dhaliwal Pharmaceuticals Laboratories LLC | 2022-12-30 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Numbing Cream | LIDOCAINE 4% | Guangxi Keyun E-commerce Co., Ltd. | 5edec844-9675-0ee7-e063-6394a90ac107 | 2026-10-27 | Warnings | 98PI200987 |
| Lidocaine 4% Patch | LIDOCAINE 4% | Highmark Pharma LLC | d0af6f74-5703-4052-9199-fcf415bc4e30 | 2026-10-26 | Warnings | 98PI200987 |
| Oeahfc Numbing Cream | MENTHOL | Shengnan (Guangzhou) Cosmetics Co., LTD | 5eb8dac6-a446-2cf6-e063-6294a90a3483 | 2026-10-26 | Warnings | L7T10EIP3A |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Lidocaine Pain Relief Patch | LIDOCAINE | GERI-CARE PHARMACEUTICAL CORP | 51b7753b-8619-6ea9-e063-6294a90a4ea4 | 2026-10-26 | Warnings | 98PI200987 |
| Eucalyptol, Menthol, Methyl Salicylate, Thymol | EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL | Old East Main Co. | 5c28847c-405f-567d-e063-6294a90a4279 | 2026-10-26 | Warnings, Adverse reactions | L7T10EIP3A |
| Family Wellness Hot and Cold Pain Relief | HOT AND COLD PAIN RELIEF | FAMILY DOLLAR (Family Wellness) | b70e343b-18aa-4e45-ae8e-79d8c84ad205 | 2026-10-26 | Warnings | L7T10EIP3A |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Coralite Cold and Hot | MENTHOL | United Exchange Corp. | 85bd7658-e951-7daf-e053-2a91aa0a9f54 | 2026-10-26 | Warnings | L7T10EIP3A |
| Nuvexa | LIDOCAINE 2.8 | Oncora Pharma, LLC | 9cb9b056-653b-4fa7-8ecf-110c84c513da | 2026-10-26 | Warnings | 98PI200987 |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| iShanCare PAIN RELIEF Gel-Patch | LIDOCARINE | Shenzhen Ishan Technology Co., Ltd | 29739289-42b6-0047-e063-6394a90ad931 | 2026-10-23 | Warnings | 98PI200987 L7T10EIP3A |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Cepacol Extra Strength Sore Throat honey lemon | BENZOCAINE AND MENTHOL | ATLANTIC BIOLOGICALS CORP. | 08160ced-e19b-443e-ab16-0d3e4ae8a8ab | 2026-10-23 | Warnings | L7T10EIP3A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.